Camtek Ltd (CAMT) Tops Q4 EPS by 1c, Slight Beat on Revenues

Camtek (CAMT) PT Raised to $12 at B.Riley/FBR

B.Riley/FBR analyst Craig Ellis raised the price target on Camtek (NASDAQ: CAMT) to $12.00 (from $10.50) while maintaining a Buy rating.

Ellis notes solid beat and raise on robust company execution.

Camtek (CAMT) PT Raised to $16 at Northland Capital Markets

Northland Capital Markets analyst Gus Richard raised the price target on Camtek (NASDAQ: CAMT) to $16.00 (from $15.00) while maintaining a Outperform rating.

Richard notes CAMT continues to significantly outperform other capital equipment companies driven by 1) Advanced packaging driving smaller and faster, 2) CMOS image sensor... More

Pre-Open Stock Movers 02/11: (NUVA) (CAR) (EA) Higher; (RGSE) (BBBY) (GT) Lower (more...)

Today's Pre-Open Movers

RGS Energy (NASDAQ: RGSE) 26.5% LOWER; announced that it will move trading of the company's Class A common stock to the OTCQX® from The Nasdaq Capital Market effective February 15, 2019.

Outlook Therapeutics (NASDAQ: OTLK) 22.8% HIGHER; disclosure late Friday that CEO Lawrence Kenyon bought 25,000 shares on 02/07 at $0.895,

NuVasive (NASDAQ: NUVA) 14.8% HIGHER; Smith & Nephew (NYSE:... More

Camtek Ltd (CAMT) Reports Agreement to Sell 20.5% Stake to Chroma Ate Inc. at $9.50/Sh

Camtek Ltd. (NASDAQ: CAMT) announced today that Chroma Ate Inc. (TAIEX: 2360), a leading Taiwanese high precision test and measurement equipment provider, has entered into a definitive agreement to acquire approximately 20.5% of the shares of Camtek, in a cash transaction.

Chroma will acquire a total of 6,117,440 Camtek shares from Priortech Ltd., the controlling shareholder of Camtek, for $58.1 million, and a further 1,700,000 new shares to be issued by Camtek, for $16.2 million. The total cash consideration to be received by Camtek and Priortech amounts to $74.3 million, and is calculated based on a share-price of $9.50 per... More